Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said ...

Zepbound, by Eli Lilly, may improve sleep apnea symptoms in those with the condition. Sleep experts explain how the weight ...

The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s ...

A new clinical trial from drugmaker Eli Lilly shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms.

Eli Lilly reported its phase 3 clinical trial data that showed showed significant reduction in sleep apnea symptoms in people ...

It is important to note that we do not need to snore or snore loudly to have sleep apnea. Unfortunately, many healthcare ...

Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults ...

T he diabetes and weight loss drug tirzepatide appears to help people with obesity who also have sleep apnea, according to ...

Disgraced movie mogul Harvey Weinstein has been hospitalised just days after his 2020 rape conviction in New York was ...

Eli Lilly said on Wednesday its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep ...

ResMed beat Wall Street estimates for quarterly profit on Wednesday due to strong demand for its sleep apnea devices, sending ...

Eli Lilly noted that tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults that have both obstructive ...